These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10715519)

  • 1. A quality control program for crossmatching procedures for solid organ transplantation. The participating laboratories of the Australasian and South Asian Tissue Typing Association.
    Howden AJ; Sayer DC; Bennett G; Smith LK; Christiansen FT
    Hum Immunol; 2000 Apr; 61(4):419-24. PubMed ID: 10715519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Italian quality control scheme for crossmatching procedures and HLA sera screening: the 2002 pilot study.
    Conca R; Praticò-Barbato L; Dall'Omo AM; Amoroso A
    Arch Pathol Lab Med; 2005 Nov; 129(11):1470-5. PubMed ID: 16253029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of SEOPF regional crossmatch trays to share kidneys for sensitized patients. Local experience of three centers.
    LeFor WM; Tardif GN; Niblack GD; Sanfilippo F
    Transplantation; 1985 Dec; 40(6):637-41. PubMed ID: 3907035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful transplantation after conversion of a positive crossmatch to negative by dissociation of IgM antibody.
    Tellis VA; Matas AJ; Senitzer D; Louis P; Glicklich D; Soberman R; Veith FJ
    Transplantation; 1989 Jan; 47(1):127-9. PubMed ID: 2643222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SEOPF high-grade match algorithm: the effect of HLA matching with ROP trays in transplanting highly sensitized patients. Southern Organ Procurement Foundation.
    Tardif GN; McCalmon RT
    Clin Transplant; 1996 Dec; 10(6 Pt 2):594-7. PubMed ID: 8996748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relevance of proficiency testing for laboratories involved in cadaveric organ transplantation and its consequences for graft survival.
    Doxiadis II; Witvliet M; Verduyn W; de Lange P; Tanke J; Schreuder GM; Persijn GG; Claas FH
    Clin Transpl; 2000; ():99-103. PubMed ID: 11512364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitization and sensitivity: defining the unsensitized patient.
    Gebel HM; Bray RA
    Transplantation; 2000 Apr; 69(7):1370-4. PubMed ID: 10798756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multilaboratory evaluation of serum analysis for HLA antibody and crossmatch reactivity by lymphocytotoxicity methods.
    Duquesnoy RJ; Marrari M
    Arch Pathol Lab Med; 2003 Feb; 127(2):149-56. PubMed ID: 12562227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concordance and discordance in anti-HLA antibody testing.
    Israeli M; Pollack MS; Shaut CA; Halpin A; DiPaola NR; Youngs D; Saidman SL;
    Transpl Immunol; 2015 Jan; 32(1):1-8. PubMed ID: 25460810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress report on the ASHI/CAP Proficiency Survey Program in Histocompatibility Testing. I. HLA-A,B,C typing, antibody screening, and lymphocytotoxicity crossmatching. American Society for Histocompatibility and Immunogenetics. College of American Pathologists.
    Marrari M; Duquesnoy RJ
    Hum Immunol; 1994 Feb; 39(2):87-95. PubMed ID: 8175387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corrected Panel-Reactive Antibody Positivity Rates for Hypersensitized Patients in Turkish Population With Calculated Panel-Reactive Antibody Software.
    Karadeniz ST; Akgul SU; Ogret Y; Ciftci HS; Bayraktar A; Bakkaloglu H; Caliskan Y; Yelekci K; Turkmen A; Aydin AE; Oguz FS; Carin M; Aydin F
    Transplant Proc; 2017 Apr; 49(3):445-447. PubMed ID: 28340809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of panel-reactive antibody in predicting crossmatch selection of cadaveric kidney recipients.
    Lieber SR; Perez FV; Tabossi MR; Persoli LB; Marques SB; Mazzali M; Alves-Filho G; de Souza CA
    Transplant Proc; 2007 Mar; 39(2):429-31. PubMed ID: 17362748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fifteen-year overview of the International Cell Exchange.
    Lau M; Terasaki P; Park MS; Barbetti A
    Clin Transpl; 1989; ():447-56. PubMed ID: 2487613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The high grade match kidney sharing algorithm of the South-Eastern Organ Procurement Foundation (SEOPF): altering recipient demographics through improved matching.
    McCune TR; Blanton JW; Thacker LR; Adams PA
    Transplantation; 1997 Sep; 64(6):860-4. PubMed ID: 9326411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation.
    Bingaman AW; Murphey CL; Palma-Vargas J; Wright F
    Transplantation; 2008 Dec; 86(12):1864-8. PubMed ID: 19104435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standardization of HLA through an international cell exchange.
    Loon J; Terasaki PI; Takemura S; Park MS
    Clin Transpl; 1987; ():453-8. PubMed ID: 3154445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulin class and specificity of antibodies causing positive T cell crossmatches. Relationship to renal transplant outcome.
    Chapman JR; Taylor CJ; Ting A; Morris PJ
    Transplantation; 1986 Dec; 42(6):608-13. PubMed ID: 3538548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. General insufficiency of the classical CDC-based crossmatch to detect donor-specific anti-HLA antibodies leading to invalid results under recipients' medical treatment or underlying diseases.
    Schlaf G; Mauz-Körholz C; Ott U; Leike S; Altermann W
    Histol Histopathol; 2012 Jan; 27(1):31-8. PubMed ID: 22127594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A special report: histocompatibility testing guidelines for hematopoietic stem cell transplantation using volunteer donors. Quality Assurance and Donor Registries Working Groups of the World Marrow Donor Association.
    Hurley CK; Wade JA; Oudshoorn M; Middleton D; Kukuruga D; Navarrete C; Christiansen F; Hegland J; Ren EC; Andersen I; Cleaver SA; Brautbar C; Raffoux C
    Hum Immunol; 1999 Apr; 60(4):347-60. PubMed ID: 10363727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.